fda approval semaglutide mash Novo's Wegovy becomes first GLP-1 drug approved for FDA Grants Accelerated Approval of
Description
Future research should continue to explore its therapeutic potential in under-studied populations, including individuals with non-diabetic cardiovascular disease and hepatic fibrosis.

Here's what you can do about it.
Youve probably heard of the semaglutide brand names Ozempic, Wegovy,
San Francisco is a leading city when it comes to health, wellness, and medical innovation